Keywords: پادگن مخصوص پروستات; dsDNA; double-stranded DNA; MIF; macrophage migration inhibitory factor; Ang-2; angiopoietin 2; CENPF; centromere protein F; Her2/neu; human epidermal growth factor receptor 2; MUC1; mucin 1; IMP2; insulin-like growth factor mRNA-binding family member 2;
مقالات ISI ترجمه شده پادگن مخصوص پروستات
مقالات ISI پادگن مخصوص پروستات (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: پادگن مخصوص پروستات; PSA; prostate-specific antigen; CT; computed tomography; MRI; magnetic resonance imaging; RARP; robotic-assisted radical prostatectomy; TAE; transarterial embolization; Synchronous colorectal and genitourinary cancer; Simultaneous endoscopic surgery; Comb
Keywords: پادگن مخصوص پروستات; prostatic neoplasms; prostate-specific antigen; neoplasm recurrence; local; prostatectomy; prognosis; ACM; all cause mortality; BCR; biochemical recurrence; CRPC; castration resistant prostate cancer; ePSADT; early PSADT; PCSM; prostate cancer specific mo
Keywords: پادگن مخصوص پروستات; Androgen deprivation; Pathology; Prostate cancer; Prostate-specific antigen; Reporting; Testosterone;
Keywords: پادگن مخصوص پروستات; AUC; area under the curve; cT; clinical stage; CI; confidence interval; DCE; dynamic contrast-enhanced; EBRT; external beam radiotherapy; ECE; extracapsular extension; GS; gleason score; GU; genito-urinary; mp; multi-parametric; MRI; magnetic resonance im
Keywords: پادگن مخصوص پروستات; prostatic neoplasms; prostate-specific antigen; mass screening; socioeconomic factors; mortality; NH; nonHispanic; NHIS; National Health Interview Survey; PM; predicted marginal; PSA; prostate specific antigen; RR; rate ratio; SEER; Surveillance, Epidemio
Keywords: پادگن مخصوص پروستات; Digital rectal exam; Family history; High-grade disease; Prostate cancer; Prostate-specific antigen; Risk prediction;
Keywords: پادگن مخصوص پروستات; Paired screen-positive design; Prostate cancer screening; Prostate-specific antigen; Reflex test; Stockholm-3 model;
Keywords: پادگن مخصوص پروستات; Prostate-specific antigen; Kinetics; Prostate cancer; Active surveillance; Outcomes;
Keywords: پادگن مخصوص پروستات; Cancer trends; Disease progression; Epidemiology; Neoplasm metastases; Prostate-specific antigen; Prostate cancer; Prostatic neoplasms; Racial disparities;
Keywords: پادگن مخصوص پروستات; detection rate; Indonesian men; prostate biopsy; prostate cancer; prostate-specific antigen;
Keywords: پادگن مخصوص پروستات; Multiple optical tweezers; Prostate-specific antigen; Fluorescence imaging; Bead-array based assay; Prostate cancer;
Keywords: پادگن مخصوص پروستات; prostatic neoplasms; biopsy; inflammation; prostate-specific antigen; risk factors; PCa; prostate cancer; PNB; prostate needle biopsy; PSA; prostate specific antigen;
Keywords: پادگن مخصوص پروستات; prostate-specific antigen; prostatic neoplasms; transplantation; graft survival; cPSA; complexed PSA; ESLD; end stage liver disease; ESRD; end stage renal disease; fPSA; free PSA; HD; hemodialysis; MMF; mycophenolate mofetil; PSA; prostate specific antige
Keywords: پادگن مخصوص پروستات; Androgen deprivation therapy; Genomics; Neuroendocrine; Gleason score; Prostate cancer; Prostate-specific antigen; Small-cell cancer;
Keywords: پادگن مخصوص پروستات; prostatic neoplasms; testosterone; hypogonadism; prostate-specific antigen; risk factors; AR; androgen receptor; BMI; body mass index; CV; coefficient of variation; MMD; median of maximum declines in 24-month screening window; MMDRM; ratio of maximum decl
Keywords: پادگن مخصوص پروستات; prostatic neoplasms; prostate-specific antigen; global burden of disease; incidence; mortality; ASDR; age standardized death rate; ASIR; age standardized incidence rate; DALY; disability adjusted life-year; GBD; Global Burden of Disease; PCa; prostate can
Keywords: پادگن مخصوص پروستات; Favorable intermediate-risk; Positive biopsy cores; Prostate-specific antigen; Upgrade; Upstage;
Keywords: پادگن مخصوص پروستات; Prostate cancer; Screening; Prostate-specific antigen; Primary care;
Keywords: پادگن مخصوص پروستات; Prostatic neoplasms; Prostate-specific antigen; Mass screening; Randomised controlled trial; Costs and cost analysis;
Keywords: پادگن مخصوص پروستات; Prostate; Prostate cancer; Prostate cancer screening; Prostate cancer screening guidelines; Prostate-specific antigen; PSA; History of prostate cancer screening; United States Preventive services Task Force;
Keywords: پادگن مخصوص پروستات; AP-1; activated protein-1; COX; cyclooxygenase; CRP; C reactive protein; DNA; deoxy-ribonucleic acid; EGF; epidermal growth factor; ery; erythrocyte; HbA1c; glycated haemoglobin; HCHO; formaldehyde; HIF-1; hypoxia induced factor; IFNG; interferon-gamma;
Keywords: پادگن مخصوص پروستات; 4- Shogaol (PubChem CID: 9794897); 6- Shogaol (PubChem CID: 5281794); Apigenin (PubChem CID: 5280443); Berberine (PubChem CID: 2353); Bergamottin (PubChem CID: 5471349); Caffeic acid (PubChem CID: 689043)Capsaicin (PubChem CID: 1548943); Cardamonin (PubCh
Keywords: پادگن مخصوص پروستات; prostatic neoplasms; prostate-specific antigen; prostatectomy; neoplasm recurrence; local; early detection of cancer; BCR; biochemical recurrence; CSS; cancer specific survival; MFS; metastasis-free survival; PSA; prostate specific antigen; RP; radical pr
Keywords: پادگن مخصوص پروستات; prostatic neoplasms; guidelines as topic; prostate-specific antigen; advisory committees; AUA; American Urological Association; ERSPC; European Randomized Study of Screening for Prostate Cancer; PCa; prostate cancer; PLCO; Prostate, Lung, Colorectal and O
Keywords: پادگن مخصوص پروستات; AA; ascorbic acid; ABTS; 2,2â²-azino-bis(3-ethylbenzthiazoline-6-sulfonicacid) diammonium salt; AEF; analytical enhancement factor; AFP; alpha fetoprotein; Anti-CEA; anticarcinoembryonic antibody; Au NBPs; gold nanobipyramids; AuNCs; gold nanoclusters; A
Keywords: پادگن مخصوص پروستات; prostatic neoplasms; prostate-specific antigen; brachytherapy; androgen antagonists; disease-free survival; ADT; androgen deprivation therapy; bDFS; biochemical disease-free survival; BF; biochemical failure; EBRT; external beam radiotherapy; LDR-BT; low
Keywords: پادگن مخصوص پروستات; prostatic neoplasms; prostate-specific antigen; data accuracy; mortality; United States Department of Veterans Affairs; EHR; electronic health record; NCDB; National Cancer Database; PSA; prostate specific antigen; SEER; Surveillance, Epidemiology and End
Keywords: پادگن مخصوص پروستات; Polydopamine; Antibody immobilization; Surface plasmon resonance; Immunoassay; Electrochemical oxidation; Prostate-specific antigen;
Keywords: پادگن مخصوص پروستات; Diabetes mellitus; Prostate cancer; Prostate-specific antigen; Grade; High-risk;
Keywords: پادگن مخصوص پروستات; ADT; androgen deprivation therapy; AE; adverse event; CRPC; castration-resistant prostate cancer; LHRH; luteinizing hormone-releasing hormone; mCRPC; metastatic CRPC; MFS; metastase-free survival; nmCRPC; non-metastatic CRPC; PFS; progression-free surviva
Keywords: پادگن مخصوص پروستات; Immunosensor; Sandwich-Type; Nanobody; Prostate-Specific antigen;
Keywords: پادگن مخصوص پروستات; LSPR; localized surface plasmon resonance; POCT; point-of-care testing; AuNPs; gold nanoparticles; AuNRs; gold nanorods; AgNPs; silver nanoparticles; AgNPRs; silver nanoprisms; Ag@AuNPs; silver-coated gold nanoparticles; Ag@AuNRs; silver-coated gold nanor
Keywords: پادگن مخصوص پروستات; AACE; American Association of Clinical Endocrinologists; BMI; body mass index; CV; cardiovascular; DM; diabetes mellitus; E2; estradiol; EMAS; European Male Aging Study; FSH; follicle-stimulating hormone; GnRH; gonadotropin-releasing hormone; HbA1c; hemog
Keywords: پادگن مخصوص پروستات; MDMA; 3,4-methylenedioxymethamphetamine; MDAI; 5,6-methylenedioxy-2-aminoindane; API; active pharmaceutical ingredient; ANFO; ammonium nitrate fuel oil; ANN; artificial neural network; CTAB; cetyltrimethylammonium bromide; CCD; charge-coupled device; CCSW
Keywords: پادگن مخصوص پروستات; prostate-specific antigen; prostate cancer; prostate biopsy; Gleason;
Keywords: پادگن مخصوص پروستات; Prostate cancer; Prostate-specific antigen; Screening; Preventive care; Minority population; Urology;
Keywords: پادگن مخصوص پروستات; Longitudinal PSA model; Prostate cancer; Prostate-specific antigen; Screening; Simulation model;
Keywords: پادگن مخصوص پروستات; Positive Surgical Margins; Prostatectomy; Prostate-Specific Antigen; Recurrence;
Keywords: پادگن مخصوص پروستات; Antibiotherapy; BPH; Prostate cancer; PSA; fPSA; free prostate-specific antigen; IPSS; International Prostate Symptom Score; Qmax; maximum flow rates; PCa; prostate cancer; PSA; prostate-specific antigen; PSAD; prostate-specific antigen density; TRUS; tra
Keywords: پادگن مخصوص پروستات; Magnetic nanoparticles; Magnetic chains; Rotating magnetic field; Brownian relaxation; Optomagnetic biosensor; Prostate-specific antigen;
Keywords: پادگن مخصوص پروستات; Biochemical failure; Conformal radiotherapy; Prostate cancer; Prostate-specific antigen; Toxicity;
Keywords: پادگن مخصوص پروستات; Cancer trends; Cause-specific mortality; Disease progression; Prostate cancer; Prostate-specific antigen;
Keywords: پادگن مخصوص پروستات; Abiraterone acetate; Androgen receptor; Metastatic castration-resistant prostate cancer; Prostate-specific antigen; Urology expert;
Keywords: پادگن مخصوص پروستات; Prostate-specific antigen; Prostate cancer; Screening;
Keywords: پادگن مخصوص پروستات; Prostatic neoplasms; Race; Castration-resistant; Abirterone acetate; Prostate-specific antigen;
Keywords: پادگن مخصوص پروستات; Prostate cancer; Prostate-specific antigen; Biomarkers; Prostate biopsy; Nomograms;
Keywords: پادگن مخصوص پروستات; Prostate cancer; Active surveillance; Nomogram; Prostate biopsy; Prostate-specific antigen;
Graphene oxide layer decorated gold nanoparticles based immunosensor for the detection of prostate cancer risk factor
Keywords: پادگن مخصوص پروستات; Prostate-specific antigen; Immunosensors; Electrochemical impedance spectroscopy; Gold nanoparticles and graphene oxide;
Keywords: پادگن مخصوص پروستات; DRE; digital rectal examination; PSA; prostate-specific antigen; USPSTF; U.S. Preventative Services Task Force;